| For: | Bellomo G. Asymptomatic hyperuricemia following renal transplantation. World J Nephrol 2015; 4(3): 324-329 [PMID: 26167455 DOI: 10.5527/wjn.v4.i3.324] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v4/i3/324.htm |
| Number | Citing Articles |
| 1 |
Adla B. Hassan, Kanz W. Ghalib, Haitham A. Jahrami, Amgad E. El-Agroudy. Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant’s Recipients: A Systematic Review. Medicina 2021; 57(6) doi: 10.3390/medicina57060525
|
| 2 |
Kejing Zhu, Yuji Jin, Weijian Liu, Cheng Wen, Xinrui Zheng, Zhixiong Li, Yunjian Chen, Yulin Niu, Wei Pan, Yong Jiang, Yingji Jin. Clinical Investigations and Therapeutic Perspectives on Metabolic Syndrome following Kidney Transplantation. Kidney and Blood Pressure Research 2025; 50(1) doi: 10.1159/000545032
|
| 3 |
Yanchun Li, Min Liu, Xuelei Zhang, Yuewu Lu, Juan Meng. Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients. Renal Failure 2019; 41(1) doi: 10.1080/0886022X.2019.1632717
|
| 4 |
Abbasi Muhammad Tanzeel, Asghar Muhammad Rashid, Bashir Khuram, Hashmi Muhammad Nauman. Hyperuricemia in Renal patients: Treat or not to treat. Archives of Clinical Nephrology 2021; doi: 10.17352/acn.000056
|
| 5 |
João Pedro Floriano, Paula C. Nahas, Flávia M. S. de Branco, Aline S. dos Reis, Luana T. Rossato, Heitor O. Santos, Larissa S. Limirio, Sebastião R. Ferreira-Filho, Erick P. de Oliveira. Serum Uric Acid Is Positively Associated with Muscle Mass and Strength, but Not with Functional Capacity, in Kidney Transplant Patients. Nutrients 2020; 12(8) doi: 10.3390/nu12082390
|
| 6 |
Xiaoyu Zi, Xi Zhang, Chuan Hao, Zhenxing Wang. Risk factors and management of hyperuricemia after renal transplantation. Frontiers in Surgery 2023; 9 doi: 10.3389/fsurg.2022.956213
|
| 7 |
Marta Ferreira, Carlos Jiménez, María Ovidia Lopez, Elena González, María José Santana, Rafael Selgas. Short-term efficacy and safety of treatment with febuxostat in kidney transplant recipient. An unicentric observational study. Nefrología (English Edition) 2018; 38(3) doi: 10.1016/j.nefroe.2017.03.010
|
| 8 |
Inese Folkmane, Lilian Tzivian, Elizabete Folkmane, Elina Valdmane, Viktorija Kuzema, Aivars Petersons. Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft Function. Medicina 2020; 56(3) doi: 10.3390/medicina56030095
|
| 9 |
Fransiska Romana Simbolon, Su‐Shin Lee, Yi‐Chun Tsai, Wen‐Chan Tsai, Gau‐Tyan Lin, Yi‐Ching Tung, Hung‐Pin Tu. Risk of incident gout in kidney transplant recipients: A retrospective cohort study. International Journal of Rheumatic Diseases 2018; 21(11) doi: 10.1111/1756-185X.13393
|
| 10 |
|
| 11 |
Larissa S. Limirio, Heitor O. Santos, Aline S. dos Reis, Erick P. de Oliveira. Association Between Dietary Intake and Serum Uric Acid Levels in Kidney Transplant Patients. Journal of Renal Nutrition 2021; 31(6) doi: 10.1053/j.jrn.2020.11.009
|
| 12 |
Api Chewcharat, Yuan‐Ting Chang, Charat Thongprayoon, Anthony Crisafio, Tarun Bathini, Michael A. Mao, Wisit Cheungpasitporn. Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta‐analysis of observational studies. Clinical Transplantation 2020; 34(4) doi: 10.1111/ctr.13820
|
| 13 |
Marta Ferreira, Carlos Jiménez, María O. Lopez, Elena González, María José Santana, Rafael Selgas. Eficacia y seguridad a corto plazo del tratamiento con febuxostat en el paciente trasplantado renal. Estudio observacional unicéntrico. Nefrología 2018; 38(3) doi: 10.1016/j.nefro.2017.03.020
|